Table I.
Variable | Total cohort (n=57) | CHD cohort (n=20) | DOT cohort (n=29) | DCS cohort (n=8) | p value |
---|---|---|---|---|---|
| |||||
Prenatal diagnosis | 49 (86%) | 15 (75%) | 26 (90%) | 8 (100%) | 0.16 |
| |||||
Gender (male) | 32 (56%) | 11 (55%) | 18 (62%) | 3 (37%) | 0.34 |
| |||||
Race | |||||
-White | 43 (75%) | 14 (70%) | 25 (86%) | 4 (50%) | 0.23 |
-African | 6 (11%) | 3 (15%) | 2 (7%) | 1 (12.5%) | |
American | 3 (5%) | 2 (10%) | 0 (0%) | 1 (12.5%) | (0.085 cauc. v. non-cauc.) |
-Hispanic | 5 (9%) | 1 (5%) | 2 (7%) | 2 (25%) | |
-Other | |||||
| |||||
Gestational Age (wks) | 38.7 ± 2.3 | 38.5 ± 1.3 | 38.7 ± 1.2 | 39 ± 1.1 | 0.65 |
| |||||
Delivery Type (C/s) | 18 (31%) | 7 (35%) | 10 (34%) | 1 (12%) | 0.47 |
| |||||
Birthweight (kg) | 3.2 ± 0.6 | 3.0 ± 0.6 | 3.3 ± 0.5 | 3.3 ± 0.7 | 0.24 |
| |||||
HC (cm) | 34.2 ± 2.2 | 33.9 ± 1.7 | 34.5 ± 1.1 | 34.1 ± 1.4 | 0.28 |
| |||||
HLHS subtype (AA) | 41 (71%) | 13 (65%) | 20 (69%) | 8 (100%) | 0.16 |
| |||||
Total maturation score (TMS) | N/A | N/A | 9.73+/−0.96 | 9.54+/−0.96 | 0.62 |
| |||||
PVL present | 11 (19%) | 4 (20%) | 5 (17%) | 2 (25%) | 0.89 |
| |||||
Age at MRI/Stage I (days) | 3.6 ± 1.9 | 3.4 ± 1.5 | 3.9 ± 2.2 | 3.2 ± 1.4 | 0.63 |
No statistical differences were observed for any of the demographics between groups. Continuous data presented as mean ±SD or % for categorical variables. Significance set at p<0.05.